Switch theme
Sign up to access all valuation multiples
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.
1959
2.4K+
LTM Revenue $2.3B
LTM EBITDA $219M
$1.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Stepan has a last 12-month revenue (LTM) of $2.3B and a last 12-month EBITDA of $219M.
In the most recent fiscal year, Stepan achieved revenue of $2.2B and an EBITDA of $192M.
Stepan expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Stepan valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | XXX | $2.2B | XXX | XXX | XXX |
| Gross Profit | $298M | XXX | $272M | XXX | XXX | XXX |
| Gross Margin | 13% | XXX | 12% | XXX | XXX | XXX |
| EBITDA | $219M | XXX | $192M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| EBIT | $97.2M | XXX | $70.8M | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $63.3M | XXX | $50.4M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $526M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 31, 2025, Stepan's stock price is $50.
Stepan has current market cap of $1.1B, and EV of $1.7B.
See Stepan trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $1.1B | XXX | XXX | XXX | XXX | $2.77 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 31, 2025, Stepan has market cap of $1.1B and EV of $1.7B.
Stepan's trades at 0.8x EV/Revenue multiple, and 9.0x EV/EBITDA.
Equity research analysts estimate Stepan's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Stepan has a P/E ratio of 17.8x.
See valuation multiples for Stepan and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 7.9x | XXX | 9.0x | XXX | XXX | XXX |
| EV/EBIT | 17.8x | XXX | 24.5x | XXX | XXX | XXX |
| EV/Gross Profit | 5.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 17.8x | XXX | 22.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 44.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialStepan's last 12 month revenue growth is 7%
Stepan's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.1M for the same period.
Stepan's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Stepan's rule of X is 27% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Stepan and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | 22% | XXX | 20% | XXX | XXX | XXX |
| Rule of 40 | 14% | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 27% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Stepan acquired XXX companies to date.
Last acquisition by Stepan was XXXXXXXX, XXXXX XXXXX XXXXXX . Stepan acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Stepan founded? | Stepan was founded in 1959. |
| Where is Stepan headquartered? | Stepan is headquartered in United States of America. |
| How many employees does Stepan have? | As of today, Stepan has 2.4K+ employees. |
| Who is the CEO of Stepan? | Stepan's CEO is Mr. Luis E. Rojo. |
| Is Stepan publicy listed? | Yes, Stepan is a public company listed on NYS. |
| What is the stock symbol of Stepan? | Stepan trades under SCL ticker. |
| When did Stepan go public? | Stepan went public in 1972. |
| Who are competitors of Stepan? | Similar companies to Stepan include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of Stepan? | Stepan's current market cap is $1.1B |
| What is the current revenue of Stepan? | Stepan's last 12 months revenue is $2.3B. |
| What is the current revenue growth of Stepan? | Stepan revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Stepan? | Current revenue multiple of Stepan is 0.8x. |
| Is Stepan profitable? | Yes, Stepan is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Stepan? | Stepan's last 12 months EBITDA is $219M. |
| What is Stepan's EBITDA margin? | Stepan's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Stepan? | Current EBITDA multiple of Stepan is 7.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
